Literature DB >> 10959691

Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.

J A Wedzicha1, T A Seemungal, P K MacCallum, E A Paul, G C Donaldson, A Bhowmik, D J Jeffries, T W Meade.   

Abstract

BACKGROUND: Respiratory tract infections may acutely increase risk from coronary heart disease (CHD), though the mechanisms have not been defined. Patients with chronic obstructive pulmonary disease (COPD) are prone to repeated exacerbations that are often associated with respiratory infections. These patients also have increased cardiovascular morbidity and mortality. We hypothesized that transient acute increases in plasma fibrinogen, an independent risk factor for CHD, could occur at COPD exacerbation (mediated through a rise in IL6) and thereby provide a mechanism linking respiratory infection to risk of coronary heart disease.
METHODS: 93 COPD patients [mean (SD) age 66.8 (8.1) years] were followed regularly over one year, with daily diary card monitoring of respiratory symptoms and peak expiratory flow rate (PEFR); 67 patients [mean FEV1 1.06 (0.44) l, FVC 2.43 (0.79) l] were seen during 120 exacerbations. At each visit spirometry was measured and blood samples taken for plasma fibrinogen and Interleukin-6 (IL-6) levels. RESULT: At baseline, the mean (SD) plasma fibrinogen was elevated at 3.9 (0.67) g/l in the 67 patients with exacerbations during the study and the median (IQR) IL-6 at 4.3 (2.4 to 6.8) pg/ml. Plasma fibrinogen increased by 0.36 (0.74) g/l at exacerbation (p <0.001). with IL-6 levels rising by 1.10 (-2.73 to 6.95) pg/ml (p = 0.008). There was a relation between the changes in fibrinogen at exacerbation and IL-6 levels (r = 0.348, p <0.001). Multiple regression revealed significantly greater rises in fibrinogen when exacerbations were associated with purulent sputum (b = 0.34 g/l; p = 0.03), increased cough (b = 0.31 g/l, p = 0.019) and symptomatic colds (b = 0.228; p = 0.024).
CONCLUSIONS: Plasma fibrinogen levels were elevated in stable patients with COPD and may contribute to the increased cardiovascular morbidity and mortality in these patients. COPD exacerbations increased serum IL-6 levels, leading to a rise in plasma fibrinogen. Thus acute rather than chronic infection may have a role in predisposing to coronary heart disease or stroke.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959691

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  117 in total

1.  Recent respiratory infection and the risk of myocardial infarction.

Authors:  T C Clayton; N E Capps; N G Stephens; J A Wedzicha; T W Meade
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 2.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

3.  Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism.

Authors:  J A Wedzicha; J R Hurst
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

Review 4.  Biomarkers in airway diseases.

Authors:  Janice M Leung; Don D Sin
Journal:  Can Respir J       Date:  2013 May-Jun       Impact factor: 2.409

Review 5.  Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials.

Authors:  Prescott G Woodruff
Journal:  Proc Am Thorac Soc       Date:  2011-08

Review 6.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

Authors:  Jeffrey L Curtis; Christine M Freeman; James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2007-10-01

Review 7.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 8.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.

Authors:  Ioannis Parastatidis; Leonor Thomson; Anne Burke; Irina Chernysh; Chandrasekaran Nagaswami; Jetze Visser; Sheryl Stamer; Daniel C Liebler; George Koliakos; Harry F G Heijnen; Garret A Fitzgerald; John W Weisel; Harry Ischiropoulos
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

10.  Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD.

Authors:  Ernest Sala; Cristina Villena; Catalina Balaguer; Angel Ríos; Carlos Fernández-Palomeque; Borja G Cosío; Javier García; Aina Noguera; Alvar Agustí
Journal:  Lung       Date:  2010-01-14       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.